Skip to main content
Log in

Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Precursor T-cell lymphoblastic leukemia/lymphoma (T-ALL/LBL) presents a mediastinal mass in one half of cases. Although the immunophenotypic features of T-ALL/LBL have been analyzed in several studies, few studies have been focused on the relationship between the anatomic distribution of lesions and immunophenotypic findings.We analyzed the clinicopathologic findings for 17 patients with T-ALL/LBL diagnosed since 1993 and whose radiologic findings were available. Data on 14 men and 3 women with a median age of 26 years (range, 10–61 years) were analyzed. On the basis of radiologic findings, the cases were divided into thymic type (n = 8) and nonthymic type (n = 9). Patients with the thymic type of T-ALL/LBL had a large mediastinal mass and minimal systemic lymphadenopathy only in the supradiaphragmatic region.Those with the nonthymic type had predominantly systemic lymphadenopathy that included infradiaphragmatic lesions. Expression of CD8 (6/7 versus 0/9) was more frequently found in the thymic type (P < .001), whereas expression of CD56 (0/7 versus 5/9) was more frequent in the nonthymic type (P = .034). In conclusion,T-ALL/LBL was divided into 2 entities, thymic type and nonthymic type, on the basis of radiologic findings and immunophenotypic features. Analysis of the expression of CD8 and CD56 would be useful for biologically classifying T-ALL/LBL into the 2 types. This study was performed in a single institution, was retrospective, and had a limited number of patients; multicenter confirmatory studies are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nathwani BN, Diamond LW, Winberg CD, et al. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer. 1981; 48:2347–2357.

    Article  PubMed  CAS  Google Scholar 

  2. Nathwani BN, Kim H, Rappaport H. Malignant lymphoma, lymphoblastic. Cancer. 1976;38:964–983.

    Article  PubMed  CAS  Google Scholar 

  3. Streuli RA, Kaneko Y, Variakojis D, Kinnealey A, Golomb HM, Rowley JD. Lymphoblastic lymphoma in adults. Cancer. 1981;47: 2510–2516.

    Article  PubMed  CAS  Google Scholar 

  4. Griffith RC, Kelly DR, Nathwani BN, et al. A morphologic study of childhood lymphoma of the lymphoblastic type: the Pediatric Oncology Group experience. Cancer. 1987;59:1126–1131.

    Article  PubMed  CAS  Google Scholar 

  5. Baldit C, Trojani M, Eghbali H, Hoerni-Simon G, Hoerni B. Lymphoblastic lymphoma with convoluted nuclei: a report of 19 cases. Oncology. 1984;41:252–256.

    Article  PubMed  CAS  Google Scholar 

  6. Morel P, Lepage E, Brice P, et al. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol. 1992;10:1078–1085.

    Article  PubMed  CAS  Google Scholar 

  7. Brunning RD, Borowitz M, Matutes E, et al. Precursor T lymphoblastic leukaemia/lymphoblastic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics—Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:115–117.

    Google Scholar 

  8. Bernard A, Boumsell L, Reinherz EL, et al. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood. 1981;57:1105–1110.

    PubMed  CAS  Google Scholar 

  9. Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res. 1983;43:4486–4490.

    PubMed  CAS  Google Scholar 

  10. Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood. 1986; 67:474–478.

    PubMed  CAS  Google Scholar 

  11. Feller AC, Parwaresch MR, Stein H, Ziegler A, Herbst H, Lennert K. Immunophenotyping of T-lymphoblastic lymphoma/leukemia: correlation with normal T-cell maturation. Leuk Res. 1986;10:1025–1031.

    Article  PubMed  CAS  Google Scholar 

  12. Knowles DM. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. Am J Pathol. 1989;134: 761–785.

    PubMed  PubMed Central  CAS  Google Scholar 

  13. Swerdlow SH, Habeshaw JA, Richards MA, Rainey M, Murray LJ, Stansfeld AG. T lymphoblastic lymphoma with LEU-7 positive phenotype and unusual clinical course: a multiparameter study. Leuk Res. 1985;9:167–173.

    Article  PubMed  CAS  Google Scholar 

  14. Sheibani K, Winberg CD, Burke JS, et al.Lymphoblastic lymphoma expressing natural killer cell-associated antigens: a clinicopathologic study of six cases. Leuk Res. 1987;11:371–377.

    Article  PubMed  CAS  Google Scholar 

  15. Sheibani K, Nathwani BN,Winberg CD, et al. Antigenically defined subgroups of lymphoblastic lymphoma: relationship to clinical presentation and biologic behavior. Cancer. 1987;60:183–190.

    Article  PubMed  CAS  Google Scholar 

  16. Pirruccello SJ, Bicak MS, Gordon BG, Gajl-Peczalska K, Gnarra DJ, Coccia PF. Acute lymphoblastic leukemia of NK-cell lineage: responses to IL-2. Leuk Res. 1989;13:735–743.

    Article  PubMed  CAS  Google Scholar 

  17. Kawano S, Tatsumi E,Yoneda N, et al. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient. Hematol Oncol. 1995;13:1–11.

    Article  PubMed  CAS  Google Scholar 

  18. Ichinohasama R, Endoh K, Ishizawa K, et al. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report. Cancer. 1996;77:2592–2603.

    Article  PubMed  CAS  Google Scholar 

  19. Koita H, Suzumiya J, Ohshima K, et al. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity. Am J Surg Pathol. 1997;21:242–248.

    Article  PubMed  CAS  Google Scholar 

  20. Nakamura S, Koshikawa T, Yatabe Y, Suchi T. Lymphoblastic lymphoma expressing CD56 and TdT. Am J Surg Pathol. 1998;22: 135–137.

    PubMed  CAS  Google Scholar 

  21. Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med. 1994;180:569–576.

    Article  PubMed  CAS  Google Scholar 

  22. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98:503–517.

    Article  PubMed  CAS  Google Scholar 

  23. Mitchell CD, Gordon I, Chessells JM. Clinical, haematological, and radiological features in T-cell lymphoblastic malignancy in childhood. Clin Radiol. 1986;37:257–261.

    Article  PubMed  CAS  Google Scholar 

  24. Kjeldsberg CR,Wilson JF, Berard CW. Non-Hodgkin’s lymphoma in children. Hum Pathol. 1983;14:612–627.

    Article  PubMed  CAS  Google Scholar 

  25. Kobashi Y, Nakamura S, Sasajima Y, et al. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Histopathology. 1996;28:111–120.

    Article  PubMed  CAS  Google Scholar 

  26. Nakamura S, Suchi T,Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol. 1995;19:284–296.

    Article  PubMed  CAS  Google Scholar 

  27. Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD56+ myeloid/ natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 1997;90:2417–2428.

    PubMed  CAS  Google Scholar 

  28. Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res. 1999;23:615–624.

    Article  PubMed  CAS  Google Scholar 

  29. Suzuki R, Murata M, Kami M, et al. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0. Int J Hematol. 2003;77:482–489.

    Article  PubMed  CAS  Google Scholar 

  30. Karube K, Ohshima K, Tsuchiya T, et al. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification. Am J Surg Pathol. 2003;27:1366–1374.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kensei Tobinai.

About this article

Cite this article

Onishi, Y., Matsuno, Y., Tateishi, U. et al. Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings. Int J Hematol 80, 43–51 (2004). https://doi.org/10.1532/IJH97.04061

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.04061

Key words

Navigation